C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/19 (2006.01) C07H 21/04 (2006.01) C07K 1/22 (2006.01) C07K 14/52 (2006.01) C07K 16/24 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12N 15/10 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2188017
Isolated CHF, isolated DNA encoding CHF, and recombinant or synthetic methods of preparing CHF are disclosed. These CHF molecules are shown to influence hypertrophic activity and neurological activity. Accordingly, these compounds or their antagonists may be used for treatment of heart failure, arrhythmic disorders, inotropic disorders, and neurological disorders.
L'invention porte sur l'isolement du facteur d'hypertrophie cardiaque (CHF également appelé cardiotrophine), sur l'ADN isolé codant le CHF, et sur des procédés de préparation du CHF par recombinaison ou par synthèse. Les molécules de CHF, ou leurs antagonistes, qui s'avèrent influencer l'activité hypertrophique et neurologique, peuvent donc être utilisées pour traiter l'insuffisance cardiaque, l'arythmie et les troubles inotropes et neurologiques.
Baker Joffre
Chien Kenneth
King Kathleen
Pennica Diane
Wood William
Dennison Associates
Genentech Inc.
The Regents Of The University Of California
LandOfFree
Cardiotrophin and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiotrophin and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotrophin and uses therefor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1690138